Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05907564 · ClinicalTrials.gov registry record · NA

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

A NA study of Cardiovascular Diseases and Pulmonary Embolism, sponsored by Inquis Medical.

Active
Registry status
NA
Development phase
130
Enrollment target
20
Study locations

NCT05907564 is a NA study of Cardiovascular Diseases and Pulmonary Embolism that is active but no longer recruiting, run by Inquis Medical. The registered enrollment target is 130 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05907564, a NA study of Cardiovascular Diseases and Pulmonary Embolism, is active but no longer recruiting, sponsored by Inquis Medical.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
130 participants
Enrollment target
20
Study locations

Study Summary

Evaluate the safety and efficacy of the Aventus Thrombectomy System for aspiration thrombectomy in subjects with acute pulmonary embolism.

Interventions

  • DEVICE Thrombectomy

Study Locations (20)

California

  • NorthBay Medical Center - Fairfield
  • MemorialCare - Long Beach
  • El Camino Health - Mountain View
  • Sutter Health - Sacramento

Michigan

  • McLaren Health Care - Bay City
  • Henry Ford Hospital - Detroit
  • Ascension Providence - Southfield

Illinois

  • Northwestern University - Chicago
  • Alexian Brothers Medical Center - Elk Grove Village

New Jersey

  • Hackensack University Medical Center - Hackensack
  • Holy Name Medical Center - Teaneck

Arizona

  • Honor Health - Scottsdale

Connecticut

  • Hartford Hospital - Hartford

District of Columbia

  • Medstar - Washington D.C.

Georgia

  • Emory University - Atlanta

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2023-09-20
Est. Completion 2026-10
Phase NA

Sponsor

Inquis Medical

1 total trials

What the Registry Record Tells You About NCT05907564

The ClinicalTrials.gov registry entry for NCT05907564 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Inquis Medical, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Thrombectomy is the first listed.

NCT05907564 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Michigan, Illinois.

Frequently Asked Questions

What is clinical trial NCT05907564 about?

NCT05907564 is a clinical study titled "Aventus Thrombectomy System Pulmonary Embolism Clinical Study". Evaluate the safety and efficacy of the Aventus Thrombectomy System for aspiration thrombectomy in subjects with acute pulmonary embolism.

What is the current status of trial NCT05907564?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2023-09-20. Estimated completion is 2026-10.

What conditions does trial NCT05907564 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Pulmonary Embolism, Vascular Diseases, Lung Diseases, Respiratory Tract Diseases.

What interventions are being tested in trial NCT05907564?

The interventions under investigation include: Thrombectomy (DEVICE).

Who is sponsoring clinical trial NCT05907564?

This trial is sponsored by Inquis Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05907564 being conducted?

This trial has 20 study locations across Arizona, California, Connecticut, District of Columbia, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.